AZTAAzenta, Inc.
What is the market doing?
No clear lean: in an uptrend and insiders net buying, but heavily shorted (+12% of shares).
In an uptrend, above its rising 50- and 200-day averages. Price is +31% vs its 200-day average.
Insiders were net buyers over the 90 days ending Oct 8, 2026.
Heavily shorted, settled Sep 15, 2026, about a week of normal trading to cover. Level with the previous count, down from 13.7% of shares outstanding three months ago.
Against the whole market›
Percentile against every name Ryufin tracks. Higher is better; the tick marks the middle of the market. Context, not one of the checks above.
Where this answer is blind. Insider selling is often routine (taxes, diversification); only cluster buying is a strong tell.
How AZTA is trading
Azenta, Inc. is +21% over the past year while the S&P 500 is +18%: 3.0 points ahead of the market.
1-year return · S&P 500 +18%
- vs 200-day average
- +31%
vs 200-day average · a clear uptrend
- RSI (14)
- 60
RSI (14) · neutral
- Below its 52-week high
- 12%
Below its 52-week high
Details›
- Last close2026-10-09
- $37.71
- 1 monthS&P 500 +2.7%
- +25%
- 1 yearS&P 500 +18%
- +21%
- 5 yearsS&P 500 +88%
- −59%
- vs 50-day average$33.44
- +13%
- 52-week high
- $42.76
- 52-week low
- $16.02
- Annualised volatility
- 59%
- Insider buying, net, 6 monthsForms 3/4/5 to 2026-10-08
- $172K
| Year | Return |
|---|---|
| 2026 (year to date) | +13% |
| 2025 | −33% |
| 2024 | −23% |
| 2023 | +12% |
| 2022 | −44% |
| 2021 | +53% |
| 2020 | +63% |
| 2019 | +62% |
| 2018 | +11% |
| 2017 | +42% |
| Month | Years | Positive | Average |
|---|---|---|---|
| Jan | 10 | 7 of 10 | +4.3% |
| Feb | 10 | 4 of 10 | −4.8% |
| Mar | 10 | 3 of 10 | −6.5% |
| Apr | 10 | 5 of 10 | +5.0% |
| May | 10 | 6 of 10 | +3.3% |
| Jun | 10 | 6 of 10 | +2.1% |
| Jul | 11 | 8 of 11 | +6.6% |
| Aug | 11 | 5 of 11 | −0.38% |
| Sep | 11 | 5 of 11 | +0.42% |
| Oct | 11 | 7 of 11 | +1.8% |
| Nov | 10 | 7 of 10 | +15% |
| Dec | 10 | 3 of 10 | −2.1% |
End-of-day closes from IEX; the S&P 500 comparison uses SPY over the same window. Prices are a reference point, not a basis for trading decisions.
Medical Instruments & Supplies
Ranks #15 of 21 by RyuScore